Our parent company EyeSense AG has its headquarters in Basel, Switzerland. It was founded in February 2006 as a spin off from Novartis and CIBA vision. Investors are BioMedinvest, Life Science Partners, Rosetta Capital, Lee’s Pharmaceutical Holding, Bayern Kapital, and Qiagen as well as other institutional and private investors.
Operations are in the German premises, in Großostheim, in the vicinity of Frankfurt.
You can find more information about our investors in the internet: